Purethal Mites — Competitive Intelligence Brief

Purethal Mites (Purethal Mites) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Allergen immunotherapy. Area: Immunology / Allergy.

phase 3 Allergen immunotherapy Dust mite allergen proteins (Der p 1, Der p 2, and related epitopes) Immunology / Allergy Biologic

Target snapshot

Purethal Mites (Purethal Mites) — Medical University of Silesia. Purethal Mites is an allergen immunotherapy product designed to desensitize patients to dust mite allergens through controlled exposure.

Comparator set (6 drugs)

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Purethal Mites TARGET	Purethal Mites	Medical University of Silesia	phase 3	Allergen immunotherapy	Dust mite allergen proteins (Der p 1, Der p 2, and related epitopes)
tree 12 SQ-Bet	tree 12 SQ-Bet	Clinique Spécialisée en Allergies de la Capitale	marketed	Allergen immunotherapy (sublingual tablet)	Tree pollen allergens (IgE cross-linking epitopes)
Cupressus arizonica	Cupressus arizonica	Laboratorios Leti, S.L.	marketed	Allergen immunotherapy
Staloral 300	Staloral 300	Medical University of Lodz	marketed	Allergen immunotherapy (sublingual tablet)	Grass pollen allergens (Phleum pratense and related species)
Staloral TM	Staloral TM	National Taiwan University Hospital	marketed	Allergen immunotherapy
HDM 12 SQ-HDM	HDM 12 SQ-HDM	Clinique Spécialisée en Allergies de la Capitale	marketed	Allergen immunotherapy (sublingual tablet)	House dust mite allergens (Der p 1, Der p 2, Der f 1, Der f 2)
PURETHAL Grasses, 20.000 AUM/ml	PURETHAL Grasses, 20.000 AUM/ml	HAL Allergy	marketed	Allergen immunotherapy extract	Grass pollen allergens (IgE and T-cell epitopes)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Allergen immunotherapy class)

1. Allergopharma GmbH & Co. KG · 8 drugs in this class
2. HAL Allergy · 2 drugs in this class
3. Medical University of Silesia · 2 drugs in this class
4. ALK-Abelló A/S · 2 drugs in this class
5. Laboratorios Leti, S.L. · 1 drug in this class
6. National Taiwan University Hospital · 1 drug in this class
7. Royal Sussex County Hospital · 1 drug in this class
8. The University of Texas Medical Branch, Galveston · 1 drug in this class
9. University of Genova · 1 drug in this class
10. Anergis · 1 drug in this class